Inhibition of Gαi activity by Gβγ is mediated by PI 3-kinase-γ- and cSrc-dependent tyrosine phosphorylation of Gαi and recruitment of RGS12

Inhibition of Gαi activity by Gβγ is mediated by PI 3-kinase-γ- and cSrc-dependent tyrosine phosphorylation of Gαi and recruitment of RGS12
复制标题

DOI:
10.1152/ajpgi.00440.2013
复制
发表时间:
2014-05-01
影响因子:
4.5
通讯作者:
Murthy, Karnam S.
Murthy, Karnam S.
中科院分区:
医学2区
文献类型:
--
作者:
Huang, Jiean;Nalli, Ancy D.;Murthy, Karnam S.

文献摘要

被引文献

相似文献

其他人和我们已经表征了平滑肌中的几种G β γ依赖性效应物,包括G蛋白偶联受体激酶2(GRK 2)、PLC β(3)和磷脂酰肌醇(PI)3-激酶-γ,并鉴定了PI 3-激酶-γ下游的各种信号传导靶点,包括cSrc、整合素连接激酶和Rac 1-Cdc 42/p21激活激酶/p38 MAP激酶。这项研究确定了一种新的机制,即G β γ通过PI 3-激酶-γ和cSrc作用,对G α(i)活性产生抑制作用。G(i2)-偶联δ-阿片受体激动剂D-青霉胺(2,5)-脑啡肽(DPDPE)激活cSrc,刺激G α(i2)的酪氨酸磷酸化,并诱导G蛋白信号转导调节因子12(RGS 12)结合;所有三个事件都被PI 3-激酶阻断(LY 294002)和cSrc(PP 2)抑制剂,并通过表达GRK 2-(495-689)(一种G β γ-清除肽)的COOH末端序列。PP 2、LY 294002和选择性PI 3-激酶-γ抑制剂AS-605420增强了DPDPE对毛喉素刺激的cAMP和肌肉松弛的抑制作用。酪氨酸缺陷型(Y 69 F、Y231 F或Y321 F)G α(i2)突变体的表达或RGS 12的敲低阻断了G α(i2)磷酸化和G α(i2)-RGS 12缔合,并引起cAMP的更大抑制。使用生长抑素、环戊基腺苷或ACh分别激活G(i1)偶联生长抑素(sstr(3))受体和G(i3)偶联腺苷A(1)或毒蕈碱m(2)受体的平行研究引起cSrc激活、G α(i1)或G α(i3)磷酸化、G α(i1)-RGS 12或G α(i3)-RGS 12缔合以及cAMP抑制。AS-605240和PP 2对cAMP和肌肉松弛的抑制作用显著增加。结果表明,通过cSrc的G α(i1/2/3)的G β γ依赖性酪氨酸磷酸化促进了RGS 12的募集,RGS 12是一种具有独特磷酸酪氨酸结合结构域的G α(i)特异性RGS蛋白,导致G α(i)快速失活并促进平滑肌松弛。
Others and we have characterized several G beta gamma-dependent effectors in smooth muscle, including G protein-coupled receptor kinase 2 (GRK2), PLC beta(3), and phosphatidylinositol (PI) 3-kinase-gamma, and have identified various signaling targets downstream of PI 3-kinase-gamma, including cSrc, integrin-linked kinase, and Rac1-Cdc42/p21-activated kinase/p38 MAP kinase. This study identified a novel mechanism whereby G beta gamma acting via PI 3-kinase-gamma and cSrc exerts an inhibitory influence on G alpha(i) activity. The G(i2)-coupled delta-opioid receptor agonist D-penicillamine (2,5)-enkephalin (DPDPE) activated cSrc, stimulated tyrosine phosphorylation of G alpha(i2), and induced regulator of G protein signaling 12 (RGS12) association; all three events were blocked by PI 3-kinase (LY294002) and cSrc (PP2) inhibitors and by expression of the COOH-terminal sequence of GRK2-(495-689), a G beta gamma-scavenging peptide. Inhibition of forskolin-stimulated cAMP and muscle relaxation by DPDPE was augmented by PP2, LY294002, and a selective PI 3-kinase-gamma inhibitor, AS-605420. Expression of tyrosine-deficient (Y69F, Y231F, or Y321F) G alpha(i2) mutant or knockdown of RGS12 blocked G alpha(i2) phosphorylation and G alpha(i2)-RGS12 association and caused greater inhibition of cAMP. Parallel studies using somatostatin, cyclopentyl adenosine, or ACh to activate, respectively, G(i1)-coupled somatostatin (sstr(3)) receptors, and G(i3)-coupled adenosine A(1) or muscarinic m(2) receptors elicited cSrc activation, G alpha(i1) or G alpha(i3) phosphorylation, G alpha(i1)-RGS12 or G alpha(i3)-RGS12 association, and inhibition of cAMP. Inhibition of cAMP and muscle relaxation was greatly increased by AS-605240 and PP2. The results demonstrate that G beta gamma-dependent tyrosine phosphorylation of G alpha(i1/2/3) by cSrc facilitated recruitment of RGS12, a G alpha(i)-specific RGS protein with a unique phosphotyrosine-binding domain, resulting in rapid deactivation of G alpha(i) and facilitation of smooth muscle relaxation.